NDC product
Ciprofloxacin Hydrochloride
NDC 82804-260 · Proficient Rx LP
Key facts
| Product NDC | 82804-260 |
|---|---|
| Proprietary name | Ciprofloxacin Hydrochloride |
| Nonproprietary name | Ciprofloxacin Hydrochloride |
| Substances | CIPROFLOXACIN HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Proficient Rx LP |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA076593 |
| Pharmacologic classes | Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS] |
| Marketing start | May 23, 2024 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: